Sort
48,018 grants matching “immunotherapy”
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$408,425Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2023 · AG
Dynamics of hematopoietic differentiation
$408,425Gregoire Altan-Bonnet · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
$408,419Andrea Facciabene · University Of Pennsylvania · R01 · FY2022 · CA
Cellular Mechanisms of PTLD in Transplant Recipients
$408,411Olivia M Martinez · Stanford University · R01 · FY2011 · AI
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$408,401Melanie R Rutkowski · University Of Virginia · R01 · FY2022 · CA
Developing a Translation Pipeline for VHL Mutant Malignancies
$408,334David McDermott · Beth Israel Deaconess Medical Center · U01 · FY2021 · CA
Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model
$408,317Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
Project 1:Therapeutically improving HNSCC antigenicity through epigenetic reprogramming
$408,242Sara Isabel Pai · Massachusetts General Hospital · P01 · FY2021 · CA
Project 1:Therapeutically improving HNSCC antigenicity through epigenetic reprogramming
$408,242Sara Isabel Pai · Massachusetts General Hospital · P01 · FY2019 · CA
Project 1:Therapeutically improving HNSCC antigenicity through epigenetic reprogramming
$408,242Sara Isabel Pai · Massachusetts General Hospital · P01 · FY2020 · CA
Project 2: Redirecting pre-existing anti-viral immunity to HNSCCs with APECs
$408,240Thorsten Roman Mempel · Massachusetts General Hospital · P01 · FY2021 · CA
Project 2: Redirecting pre-existing anti-viral immunity to HNSCCs with APECs
$408,238Mark Cobbold · Massachusetts General Hospital · P01 · FY2019 · CA
Project 2: Redirecting pre-existing anti-viral immunity to HNSCCs with APECs
$408,238Mark Cobbold · Massachusetts General Hospital · P01 · FY2020 · CA
ALDH Inhibition as Modulator of Tumor Immunobiology
$408,231Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2024 · CA
Accelerated CD8 T cell memory after DC vaccination
$408,184John T. Harty · University Of Iowa · R01 · FY2007 · AI
Effects of cholinergic axonal plasticity on spatial orientation
$408,171Douglas Wallace · Northern Illinois University · R15 · FY2018 · AG
Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer
$408,091Reza Dastvan · Saint Louis University · R01 · FY2023 · GM
Directing Function at the Natural Killer Cell Secretory Immunological Synapse
$408,066Jordan Scott Orange · Baylor College Of Medicine · R01 · FY2016 · AI
The structural and functional basis of MET exon 14 activation and acquired drug resistance
$408,060Natalia Jura · University Of California, San Francisco · R01 · FY2019 · CA
Project 1
$408,054Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · P01 · FY2025 · AI
Critical Role for Microvasculature in Airway Transplantation
$408,029Mark Robert Nicolls · Palo Alto Veterans Instit For Research · R01 · FY2022 · HL
Immune Response to Polyomavirus Infection
$408,025Parmjeet S Randhawa · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · AI
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$408,013Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2022 · NS
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
$407,966Yoon Yeo · Purdue University · R01 · FY2020 · CA
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
$407,966Yoon Yeo · Purdue University · R01 · FY2021 · CA